These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19711497)

  • 21. Twenty years post-NIH Revitalization Act: enhancing minority participation in clinical trials (EMPaCT): laying the groundwork for improving minority clinical trial accrual: renewing the case for enhancing minority participation in cancer clinical trials.
    Chen MS; Lara PN; Dang JH; Paterniti DA; Kelly K
    Cancer; 2014 Apr; 120 Suppl 7(0 7):1091-6. PubMed ID: 24643646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials.
    Tejeda HA; Green SB; Trimble EL; Ford L; High JL; Ungerleider RS; Friedman MA; Brawley OW
    J Natl Cancer Inst; 1996 Jun; 88(12):812-6. PubMed ID: 8637047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting accrual achievement: monitoring accrual milestones of NCI-CTEP-sponsored clinical trials.
    Cheng SK; Dietrich MS; Dilts DM
    Clin Cancer Res; 2011 Apr; 17(7):1947-55. PubMed ID: 21447723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What factors influence minority use of National Cancer Institute-designated cancer centers?
    Huang LC; Ma Y; Ngo JV; Rhoads KF
    Cancer; 2014 Feb; 120(3):399-407. PubMed ID: 24452674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era.
    Roth ME; Unger JM; O'Mara AM; Lewis MA; Budd T; Johnson RH; Pollock BH; Blanke C; Freyer DR
    Cancer Med; 2020 Mar; 9(6):2146-2152. PubMed ID: 32009305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing minority participation in cancer clinical trials: the minority-based community clinical oncology program experience.
    McCaskill-Stevens W; McKinney MM; Whitman CG; Minasian LM
    J Clin Oncol; 2005 Aug; 23(22):5247-54. PubMed ID: 16051967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Positive SWOG Treatment Trials on Survival of Patients With Cancer in the US Population.
    Unger JM; LeBlanc M; Blanke CD
    JAMA Oncol; 2017 Oct; 3(10):1345-1351. PubMed ID: 28586789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enrolling Older Adults Onto National Cancer Institute-Funded Clinical Trials in Community Oncology Clinics: Barriers and Solutions.
    Hopkins JO; Braun-Inglis C; Guidice S; Wells M; Moorthi K; Berenberg J; St Germain D; Mohile S; Hudson MF
    J Natl Cancer Inst Monogr; 2022 Dec; 2022(60):117-124. PubMed ID: 36519815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.
    Movsas B; Moughan J; Owen J; Coia LR; Zelefsky MJ; Hanks G; Wilson JF
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1145-50. PubMed ID: 17418963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP-sponsored clinical trials before and after launch of the NCI National Clinical Trials Network.
    Sankaran H; Finnigan SR; McShane LM; Best AF; Seibel NL
    Cancer; 2022 Nov; 128(21):3843-3849. PubMed ID: 36089859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Representation of older patients in cancer treatment trials.
    Trimble EL; Carter CL; Cain D; Freidlin B; Ungerleider RS; Friedman MA
    Cancer; 1994 Oct; 74(7 Suppl):2208-14. PubMed ID: 8087794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Representation of Asian Americans in clinical cancer trials.
    Alexander GA; Chu KC; Ho RC
    Ann Epidemiol; 2000 Nov; 10(8 Suppl):S61-67. PubMed ID: 11189094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic proximity and racial disparities in cancer clinical trial participation.
    Kanarek NF; Tsai HL; Metzger-Gaud S; Damron D; Guseynova A; Klamerus JF; Rudin CM
    J Natl Compr Canc Netw; 2010 Dec; 8(12):1343-51. PubMed ID: 21147901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
    Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
    Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Trial Characteristics and Barriers to Participant Accrual: The MD Anderson Cancer Center Experience over 30 years, a Historical Foundation for Trial Improvement.
    Tang C; Sherman SI; Price M; Weng J; Davis SE; Hong DS; Yao JC; Buzdar A; Wilding G; Lee JJ
    Clin Cancer Res; 2017 Mar; 23(6):1414-1421. PubMed ID: 28275168
    [No Abstract]   [Full Text] [Related]  

  • 36. Organizational designs for achieving high treatment trial enrollment: a fuzzy-set analysis of the community clinical oncology program.
    Weiner BJ; Jacobs SR; Minasian LM; Good MJ
    J Oncol Pract; 2012 Sep; 8(5):287-91. PubMed ID: 23277765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National Cancer Institute's Cancer Disparities Research Partnership Program: Experience and Lessons Learned.
    Wong RS; Vikram B; Govern FS; Petereit DG; Maguire PD; Clarkson MR; Heron DE; Coleman CN
    Front Oncol; 2014; 4():303. PubMed ID: 25405101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The association between severe maternal morbidity and mortality and race/ethnicity with community type in Maryland.
    Cudjoe LN; Canner JK; Lawson SM; Vaught AJ
    Womens Health (Lond); 2023; 19():17455057231189556. PubMed ID: 37615167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
    St Germain D; Denicoff AM; Dimond EP; Carrigan A; Enos RA; Gonzalez MM; Wilkinson K; Mathiason MA; Duggan B; Einolf S; McCaskill-Stevens W; Bryant DM; Thompson MA; Grubbs SS; Go RS
    J Oncol Pract; 2014 Mar; 10(2):e73-80. PubMed ID: 24424313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accrual to the Breast Cancer Prevention Trial by participating Community Clinical Oncology Programs: a panel data analysis.
    Klabunde CN; Kaluzny AD
    Breast Cancer Res Treat; 1995 Jul; 35(1):43-50. PubMed ID: 7612903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.